These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25808511)

  • 1. 4-Fluoroamphetamine in the Netherlands: more than a one-night stand.
    Linsen F; Koning RP; van Laar M; Niesink RJ; Koeter MW; Brunt TM
    Addiction; 2015 Jul; 110(7):1138-43. PubMed ID: 25808511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatalities, Cerebral Hemorrhage, and Severe Cardiovascular Toxicity After Exposure to the New Psychoactive Substance 4-Fluoroamphetamine: A Prospective Cohort Study.
    Hondebrink L; Nugteren-van Lonkhuyzen JJ; Rietjens SJ; Brunt TM; Venhuis B; Soerdjbalie-Maikoe V; Smink BE; van Riel AJHP; de Vries I
    Ann Emerg Med; 2018 Mar; 71(3):294-305. PubMed ID: 28969928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
    van der Gouwe D; Brunt TM; van Laar M; van der Pol P
    Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users.
    Brunt TM; Koeter MW; Niesink RJ; van den Brink W
    Psychopharmacology (Berl); 2012 Apr; 220(4):751-62. PubMed ID: 21993879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Instability of the ecstasy market and a new kid on the block: mephedrone.
    Brunt TM; Poortman A; Niesink RJ; van den Brink W
    J Psychopharmacol; 2011 Nov; 25(11):1543-7. PubMed ID: 20826554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug testing in Europe: monitoring results of the Trans European Drug Information (TEDI) project.
    Brunt TM; Nagy C; Bücheli A; Martins D; Ugarte M; Beduwe C; Ventura Vilamala M
    Drug Test Anal; 2017 Feb; 9(2):188-198. PubMed ID: 26888408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.
    Davis AK; Rosenberg H
    J Psychoactive Drugs; 2014; 46(2):154-61. PubMed ID: 25052792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is online information on ecstasy tablet content safe?
    Vrolijk RQ; Brunt TM; Vreeker A; Niesink RJ
    Addiction; 2017 Jan; 112(1):94-100. PubMed ID: 27518128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring new psychoactive substances (NPS) in The Netherlands: data from the drug market and the Poisons Information Centre.
    Hondebrink L; Nugteren-van Lonkhuyzen JJ; Van Der Gouwe D; Brunt TM
    Drug Alcohol Depend; 2015 Feb; 147():109-15. PubMed ID: 25541244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Content of ecstasy in the Netherlands: 1993-2008.
    Vogels N; Brunt TM; Rigter S; van Dijk P; Vervaeke H; Niesink RJ
    Addiction; 2009 Dec; 104(12):2057-66. PubMed ID: 19804461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the Attractiveness of New Psychoactive Substances (NPS) among Experienced Drug Users.
    van Amsterdam JG; Nabben T; Keiman D; Haanschoten G; Korf D
    J Psychoactive Drugs; 2015; 47(3):177-81. PubMed ID: 26098724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mCPP: an undesired addition to the ecstasy market.
    Bossong MG; Brunt TM; Van Dijk JP; Rigter SM; Hoek J; Goldschmidt HM; Niesink RJ
    J Psychopharmacol; 2010 Sep; 24(9):1395-401. PubMed ID: 19304863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students.
    Brière FN; Fallu JS; Janosz M; Pagani LS
    J Epidemiol Community Health; 2012 Nov; 66(11):990-4. PubMed ID: 22516739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-mortem cases involving amphetamine-based drugs in The Netherlands. Comparison with driving under the influence cases.
    Verschraagen M; Maes A; Ruiter B; Bosman IJ; Smink BE; Lusthof KJ
    Forensic Sci Int; 2007 Aug; 170(2-3):163-70. PubMed ID: 17658708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater sexual risk-taking in female and male recreational MDMA/ecstasy users compared with alcohol drinkers: a questionnaire study.
    May AL; Parrott AC
    Hum Psychopharmacol; 2015 Jul; 30(4):272-5. PubMed ID: 26216562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do police arrestees substitute legal highs for other drugs?
    Wilkins C; Parker K; Prasad J; Jawalkar S
    Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study.
    Scholey AB; Parrott AC; Buchanan T; Heffernan TM; Ling J; Rodgers J
    Addict Behav; 2004 Jun; 29(4):743-52. PubMed ID: 15135556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent elevation of peripheral oxytocin concentrations and reduction in cognitive empathy during 4-fluoroamphetamine intoxication.
    Dolder PC; de Sousa Fernandes Perna EB; Mason NL; Hutten NRPW; Toennes SW; Theunissen EL; Ramaekers JG; Kuypers KPC
    Hum Psychopharmacol; 2018 Nov; 33(6):e2680. PubMed ID: 30357914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs on the street: an introduction.
    Singer M
    J Ethn Subst Abuse; 2005; 4(2):1-7. PubMed ID: 16275632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.